CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

23 hedge funds and large institutions have $11.3M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$413K
2 +$322K
3 +$311K
4
BL
BCWM LLC
Kansas
+$131K
5
Morgan Stanley
Morgan Stanley
New York
+$62.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.32M
2
$1.01M
3
$1M
4
$818K
5
$745K
6
$504K
7
$414K
8
$413K
9
$322K
10
$299K
11
$181K
12
$69.1K
13
$46K
14
$34K
15
$31K
16
$23K
17
$16K
18
$13K
19
$7K
20
$6K
21
$3K
22
$3K
23
$1K
24
25